Epitomee's presentation will cover the following topics:
- The Epitomee Platform enables oral delivery of significant amounts of large molecules, including proteins and peptides.
- The platform dramatically boosts bioavailability, offering game-changing alternative to traditional injections.
- Epitomee's advanced, needle-free platform precisely transports drugs to the small intestine and across the GI wall, ensuring effective bioavailability.
The PODD Conference, in its 14th year, brings together over 800+ delegates from pharma, biotech, drug delivery, investors and academia. The event fosters collaboration across industries, to develop more effective therapies, improve the patient experience and extend the lifecycle of medicines. PODD features innovative technologies to enhance the delivery of various drug types, including proteins, peptides, oncology therapeutics, small molecules and others. This year's annual keynote will be delivered by Dr. Robert Langer of MIT.
Join us at PODD 2024 to learn how Epitomee Medical is transforming biologics delivery.
About Epitomee Medical:
Epitomee Medical, co-founded by Shimon Eckhouse, PhD and led by CEO Dan Hashimshony, PhD, is a pioneering health solutions company, committed to advancing innovative therapies. With a focus on safety, efficacy, and improving quality of life, Epitomee leads advancements in weight management and biologic drug delivery. For more information, visit: epitomeemedical.com
Contact details: Safi Landskroner, VP of Business Development: [email protected]
Photo - https://mma.prnewswire.com/media/2530888/PODD_2024.jpg
Logo - https://mma.prnewswire.com/media/2506356/Epitomee_Medical_Logo.jpg
Share this article